powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013205145
Qi Cui
M.D., PH.D.
Ophthalmology
Philadelphia,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 390111
Hospital
CCN 390223
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,766
Beneficiaries
—
Total drug cost
$92K
Distinct drugs
12
Brand share
23.2%
Top prescribed drugs
Latanoprost
621 claims
Brimonidine Tartrate
390 claims
Dorzolamide Hcl/Timolol Maleat
300 claims
Dorzolamide Hcl
152 claims
Timolol Maleate
72 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
633
Unique beneficiaries
—
Total services
657
Distinct HCPCS
10
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 810 Ophthalmology providers in PA — bottom quintile (cohort median 1,854).